Skip to content
DeepViews

LeMaitre Vascular, Inc. (LMAT) — 分析摘要

LeMaitre Vascular, Inc.(LMAT)的市值为1.90十亿美元,最近一年的营收同比增长了+13.5%。净利润率为23.1%。当前市盈率为28.9倍。

核心要点

  • 营收同比变化+13.5%
  • 净利润率23.1%
  • 市盈率28.9倍

与SURGICAL & MEDICAL INSTRUMENTS & APPARATUS板块的其他公司相比,LMAT的营收增长为+13.5%,市盈率为28.9倍。

[XNAS]

LeMaitre Vascular, Inc. (LMAT)

$82.91

前收盘价 2026-10-12 · 市场数据 POLYGON · 财务数据 SEC EDGAR

市值
$1896.09M
企业价值
$1519.85M
市盈率
28.9
股息率
1.21%
EV/EBITDA
17.3
公司简介
关于
关于 LeMaitre Vascular, Inc.

LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.

行业

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

员工人数

655

总部

BURLINGTON, MA

Exchange

XNAS

官网
Source: Polygon.io
评分
竞争壁垒
竞争壁垒
75
宽护城河

基于 4 年财务数据的系统性竞争优势评估

此评估基于历史财务数据的量化分析,不构成投资建议。护城河评级可能随行业和竞争环境变化。

市场信号
估值
盈利
内部人交易
内部人备案活动

首版展示近期 SEC Forms 3、4、5 备案活动。尚未解析单笔买入/卖出交易。

加载 SEC 内部人备案数据...
超级投资者
财务健康
财务健康

资本结构

总权益$420.34M
总债务$0.00M
债务权益比0.00
现金及等价物$26.63M

现金流

经营现金流$82.98M
自由现金流$73.83M
自由现金流率28.13%
P/FCF 比率25.68
Source: Polygon.io · SEC EDGAR
股息
股息

年度每股股息

$1.00

股息收益率

1.21%

季度
最近除息日: 2026-08-20

股息历史

2026-08-20
CD$0.2500
2026-05-21
CD$0.2500
2026-03-12
CD$0.2500
2025-11-20
CD$0.2000
Source: Polygon.io
最新资讯
Recent News

免责声明:本站内容不构成投资建议。数据来源于SEC EDGAR和Polygon.io。过往业绩不代表未来表现。投资决策前请自行研究。